Cano Health (CANO) Tops Q1 EPS by 4c; FY22 Guidance

Cano Health (NYSE: CANO) reported Q1 EPS of $0.00, $0.04 better than the analyst estimate of ($0.04). Revenue for the quarter came in at $704.3 million versus the consensus estimate of $666.03 million.

GUIDANCE:

Cano Health sees FY2022 revenue of $2.8-2.9 billion.

For earnings history and earnings-related data on Cano Health (CANO) click here.

You May Also Be Interested In

• Methode Electronics (MEI) Tops Q1 EPS by 2c; offers guidance
• NIO Inc. (NIO) Tops Q2 EPS by 33c; offers guidance
• Five Below raises full-year outlook after strong second-quarter sales growth